Pirfenidone vs nintedanib in progressive fibrosing ILD beyond IPF: real-world treatment selection?
Antifibrotic Therapy in Progressive Rheumatoid Arthritis-Associated Interstitial Lung Disease with a Usual Interstitial Pneumonia Pattern: Expert Perspectives on Treatment Selection and Monitoring